Samil Pharm (000520) — Free Cash Flow Generation Index
Latest as of June 2025:
-0.33x
Samil Pharm (000520) has a Free Cash Flow Generation Index of -0.33x as of June 2025. Free cash flow of ₩-814.57 Million represents 0% of operating cash flow (₩2.44 Billion). Read 000520 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
-0.33x
Free Cash Flow / Operating CF
Free Cash Flow
₩-814.57 Million
KRW
Operating Cash Flow
₩2.44 Billion
KRW
Capital Expenditures
₩3.26 Billion
KRW
Samil Pharm Free Cash Flow Generation Index (2012–2024)
Historical FCF Generation Index trend for Samil Pharm across 10 annual periods. Explore Samil Pharm capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Samil Pharm (2012–2024)
Year-by-year Free Cash Flow Generation Index for Samil Pharm. For the full company profile including market capitalisation, see 000520 market cap.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.17x | ₩-3.02 Billion | ₩2.59 Billion | ₩5.61 Billion | ▼ -8.4% |
| 2023 | -1.08x | ₩-12.65 Billion | ₩11.75 Billion | ₩24.39 Billion | ▲ +90.0% |
| 2022 | -10.71x | ₩-44.50 Billion | ₩4.15 Billion | ₩48.48 Billion | ▲ +52.1% |
| 2021 | -22.35x | ₩-31.67 Billion | ₩1.42 Billion | ₩32.83 Billion | ▼ -1741.9% |
| 2020 | -1.21x | ₩-9.44 Billion | ₩7.77 Billion | ₩17.02 Billion | ▼ -230.4% |
| 2019 | -0.37x | ₩-3.89 Billion | ₩10.59 Billion | ₩13.89 Billion | ▲ +96.5% |
| 2017 | -10.43x | ₩-39.55 Billion | ₩3.79 Billion | ₩36.33 Billion | ▼ -682.6% |
| 2016 | 1.79x | ₩10.09 Billion | ₩5.63 Billion | ₩4.45 Billion | ▼ -0.9% |
| 2015 | 1.81x | ₩5.28 Billion | ₩2.92 Billion | ₩2.36 Billion | ▲ +31.0% |
| 2012 | 1.38x | ₩6.93 Billion | ₩5.02 Billion | ₩1.91 Billion | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).